Lotus Bio-Technology Development Operating Income

The latest operating income for LBTD is $-770K as of December 2017. That compares with $-790K in the prior-year period — up 1.5% year over year. Investors often review this figure alongside Lotus Bio-Technology Development's historical trend and sector peers before judging valuation or financial health.

Over the past year, LBTD's operating income moved from $-790K to $-770K — a 1.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Lotus Bio-Technology Development's operating scale or balance-sheet position.

A operating income figure of $-770K for LBTD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LBTD's operating income ($-770K), review year-over-year change from $-790K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.